NCT01248507View on ClinicalTrials.gov

Predictive Questionnaires for Risk of Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbations

CompletedOBSERVATIONAL
Enrollment

634

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
COPD
Trial Locations (1)

28023

Nycomed Pharma S.A., Madrid

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY